Clinical trials
Phase 2/3 Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Suspended | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 2 |
| Eisai Limited | 1 |
| Guangzhou Medical University | 1 |
| NRG Oncology | 1 |
| Rambam Health Care Campus | 1 |
| Samsung Medical Center | 1 |
| Tata Memorial Centre | 1 |
| University of California, San Diego | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma | 9 |
| Oropharyngeal Neoplasms | 3 |
| Hypopharyngeal Neoplasms | 2 |
| Laryngeal Neoplasms | 2 |
| Mouth Neoplasms | 2 |
| Squamous Cell Carcinoma of Head and Neck | 2 |
| Adenocarcinoma | 1 |
| Bile Duct Diseases | 1 |
| Biliary Tract Diseases | 1 |
| Carcinoma, Hepatocellular | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.